4
Changes in Ownership
aTYR PHARMA INC Filed Acc 0001209191-16-113590
CEO and Director bought 2,500 shares at $3.52 ($8,800)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| MENDLEIN JOHN CEO and Director | 2016-04-05 | Purchase | +2,500 | $3.52 | $8,800 | 250,971 | D |
| Open-market purchases · 2,500 sh · avg $3.52 · $8,800 | |||||||
Loading xslF345X03/doc4.xml…